ロード中...
Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
[Image: see text] Prostate cancer (PCa) is the second most common cause of cancer death among American men after lung cancer. Unfortunately, current therapies do not provide effective treatments for patients with advanced, metastatic, or hormone refractory disease. Therefore, we seek to generate the...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Chemical
Society
2014
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4198102/ https://ncbi.nlm.nih.gov/pubmed/25157916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bc500362n |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|